13D/13G Filings - Point72 Asset Management, L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, ...6, 7, 8, 9, 10, ...18, 19, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-02-14
06:16 am
Sale
2023-12-31 13G Iovance Biotherapeutics, Inc.
IOVA
Point72 Asset Management, L.P. 468,821
0.200%
-7,646,069decrease
(-94.22%)
Filing
History
2024-02-14
06:15 am
Sale
2023-12-31 13G Fastly, Inc.
FSLY
Point72 Asset Management, L.P. 68,184
0.100%
-6,141,507decrease
(-98.90%)
Filing
History
2024-02-14
06:11 am
Sale
2023-12-31 13G Esperion Therapeutics, Inc.
ESPR
Point72 Asset Management, L.P. 209,971
0.200%
-4,323,785decrease
(-95.37%)
Filing
History
2024-02-14
06:03 am
Sale
2023-12-31 13G Longboard Pharmaceuticals, Inc.
LBPH
Point72 Asset Management, L.P. 825,000
3.800%
-425,000decrease
(-34.00%)
Filing
History
2024-02-14
06:01 am
Sale
2023-12-31 13G CUTERA INC
CUTRQ
Point72 Asset Management, L.P. 214,800
1.100%
-929,607decrease
(-81.23%)
Filing
History
2024-02-12
4:24 pm
Purchase
2024-02-02 13G Annexon, Inc.
ANNX
Point72 Asset Management, L.P. 4,868,603
6.200%
4,868,603increase
(New Position)
Filing
History
2024-02-09
4:08 pm
Purchase
2024-02-06 13G Vaccinex, Inc.
VCNX
Point72 Asset Management, L.P. 413,818
9.900%
413,818increase
(New Position)
Filing
History
2024-02-08
4:53 pm
Purchase
2024-02-07 13G JOYY Inc.
JOYY
Point72 Asset Management, L.P. 45,329,900
5.100%
45,329,900increase
(New Position)
Filing
History
2024-02-07
4:25 pm
Purchase
2024-02-06 13G Alto Neuroscience, Inc.
ANRO
Point72 Asset Management, L.P. 1,692,778
6.300%
1,692,778increase
(New Position)
Filing
History
2024-02-05
4:34 pm
Purchase
2024-02-02 13G Sagimet Biosciences Inc.
SGMT
Point72 Asset Management, L.P. 1,612,639
5.300%
1,612,639increase
(New Position)
Filing
History
2024-01-31
4:55 pm
Purchase
2024-01-30 13G Iterum Therapeutics plc
ITRM
Point72 Asset Management, L.P. 850,001
6.300%
850,001increase
(New Position)
Filing
History
2024-01-31
4:54 pm
Purchase
2024-01-30 13G Arcutis Biotherapeutics, Inc.
ARQT
Point72 Asset Management, L.P. 4,867,706
5.200%
3,680,108increase
(+309.88%)
Filing
History
2024-01-29
4:40 pm
Purchase
2024-01-26 13G Corbus Pharmaceuticals Holdings, Inc.
CRBP
Point72 Asset Management, L.P. 388,676
8.800%
388,676increase
(New Position)
Filing
History
2024-01-25
4:19 pm
Purchase
2024-01-24 13G Fate Therapeutics, Inc.
FATE
Point72 Asset Management, L.P. 4,945,146
5.000%
4,945,146increase
(New Position)
Filing
History
2024-01-04
4:15 pm
Purchase
2024-01-03 13G C4 Therapeutics, Inc.
CCCC
Point72 Asset Management, L.P. 2,676,696
5.400%
2,676,696increase
(New Position)
Filing
History
2024-01-02
4:15 pm
Purchase
2023-12-21 13G Syros Pharmaceuticals, Inc.
SYRS
Point72 Asset Management, L.P. 1,471,771
5.700%
1,471,771increase
(New Position)
Filing
History
2023-12-28
4:15 pm
Purchase
2023-12-27 13G PagSeguro Digital Ltd.
PAGS
Point72 Asset Management, L.P. 10,702,598
5.100%
8,012,692increase
(+297.88%)
Filing
History
2023-12-18
4:15 pm
Purchase
2023-12-07 13G Protagonist Therapeutics, Inc.
PTGX
Point72 Asset Management, L.P. 3,186,077
5.500%
2,818,071increase
(+765.77%)
Filing
History
2023-12-11
4:15 pm
Purchase
2023-11-29 13G Amylyx Pharmaceuticals, Inc.
AMLX
Point72 Asset Management, L.P. 3,470,691
5.100%
3,470,691increase
(New Position)
Filing
History
2023-12-01
4:15 pm
Purchase
2023-11-30 13G FARFETCH LTD
FTCHQ
Point72 Asset Management, L.P. 18,765,409
5.300%
18,765,409increase
(New Position)
Filing
History
Goto Prev, 0, 1, ...6, 7, 8, 9, 10, ...18, 19, Next